These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 8641007

  • 1. Processing of chimeric antisense oligonucleotides by human vascular smooth muscle cells and human atherosclerotic plaque. Implications for antisense therapy of restenosis after angioplasty.
    Pickering JG, Isner JM, Ford CM, Weir L, Lazarovits A, Rocnik EF, Chow LH.
    Circulation; 1996 Feb 15; 93(4):772-80. PubMed ID: 8641007
    [Abstract] [Full Text] [Related]

  • 2. Uptake kinetics of 99mTc-MAG3-antisense oligonucleotide to PCNA and effect on gene expression in vascular smooth muscle cells.
    Zhang YR, Zhang YX, Cao W, Lan XL.
    J Nucl Med; 2005 Jun 15; 46(6):1052-8. PubMed ID: 15937319
    [Abstract] [Full Text] [Related]

  • 3. [Antisense oligonucleotides inhibit c-myc and PCNA expression in the vascular smooth muscle cells].
    Bian J, Zhang B, Chen S.
    Zhonghua Yi Xue Za Zhi; 1999 Jan 15; 79(1):10-4. PubMed ID: 11600998
    [Abstract] [Full Text] [Related]

  • 4. [Suppression of vascular smooth muscle cell proliferation by an antisense oligonucleotide against PDGF receptor].
    Sugiki H.
    Hokkaido Igaku Zasshi; 1995 May 15; 70(3):485-95. PubMed ID: 7590599
    [Abstract] [Full Text] [Related]

  • 5. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.
    Morishita R, Gibbons GH, Ellison KE, Nakajima M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ.
    Proc Natl Acad Sci U S A; 1993 Sep 15; 90(18):8474-8. PubMed ID: 8104336
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antisense oligonucleotides directed at cell cycle regulatory genes as strategy for restenosis therapy.
    Morishita R, Gibbons GH, Ellison KE, Nakajima M, von der Leyen H, Zhang L, Kaneda Y, Ogihara T, Dzau VJ.
    Trans Assoc Am Physicians; 1993 Sep 15; 106():54-61. PubMed ID: 8036745
    [No Abstract] [Full Text] [Related]

  • 13. Antisense oligonucleotides to the p65 subunit of NF-kB inhibit human vascular smooth muscle cell adherence and proliferation and prevent neointima formation in rat carotid arteries.
    Autieri MV, Yue TL, Ferstein GZ, Ohlstein E.
    Biochem Biophys Res Commun; 1995 Aug 24; 213(3):827-36. PubMed ID: 7654244
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo transport and delivery of phosphorothioate oligonucleotides with cationic liposomes.
    Miyano-Kurosaki N, Barnor JS, Takeuchi H, Owada T, Nakashima H, Yamamoto N, Matsuzaki T, Shimada F, Takaku H.
    Antivir Chem Chemother; 2004 Mar 24; 15(2):93-100. PubMed ID: 15185727
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.